Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totaling 4,300 shares, a growth of 168.8% from the September 15th total of 1,600 shares. Based on an average daily volume of 3,600 shares, the short-interest ratio is currently 1.2 days. Based on an average daily volume of 3,600 shares, the short-interest ratio is currently 1.2 days.
Aspen Pharmacare Price Performance
Shares of APNHY stock opened at $5.78 on Friday. The company has a quick ratio of 1.18, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Aspen Pharmacare has a 52-week low of $5.24 and a 52-week high of $10.48. The company has a 50-day simple moving average of $5.88 and a two-hundred day simple moving average of $6.52.
Aspen Pharmacare Announces Dividend
The firm also recently declared a dividend, which will be paid on Tuesday, October 21st. Investors of record on Monday, October 6th will be given a dividend of $0.0725 per share. This represents a dividend yield of 138.0%. The ex-dividend date of this dividend is Friday, October 3rd.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- What is the MACD Indicator and How to Use it in Your Trading
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- Using the MarketBeat Dividend Yield Calculator
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.